Viewing Study NCT02148861


Ignite Creation Date: 2025-12-24 @ 12:42 PM
Ignite Modification Date: 2025-12-25 @ 12:13 PM
Study NCT ID: NCT02148861
Status: COMPLETED
Last Update Posted: 2021-03-08
First Post: 2014-04-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module